Declining for the third consecutive session, gold prices have tumbled on Friday as traders parse the claims made by U.S. President Donald Trump that Iran would surrender ...
This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas such ...